JORDAN MONTOYA: Open Payments
NPI 1073199972 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 26 payments from 11 companies in 2025. Trend: 2023 $1,018 · 2024 $703 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $166 |
| ABBVIE INC. | 11 | $162 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $37 |
| Incyte Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| UCB, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $19 |
| Surgenex LLC | 1 | $18 |
Products named: TREMFYA, SKYRIZI, RINVOQ, COSENTYX, OPZELURA, TALTZ, Bimzelx, DUPIXENT.
Industry payments across MO — which companies pay providers there.
